Ingredient Guide
Graviola (Soursop): Benefits, Dosage, and What the Research Says
A tropical fruit packed with antioxidants - here is what peer-reviewed research actually shows.
Written by Jessica Medson
Graviola (Annona muricata), commonly called soursop, is a tropical fruit tree native to the Americas and widely used in traditional medicine throughout the Caribbean, Latin America, and West Africa. The leaves, fruit, bark, and roots contain a diverse array of antioxidant polyphenols and flavonoids. One 12-week RCT in 143 prehypertensive adults found that consuming 200 g of soursop juice daily significantly lowered systolic blood pressure and serum uric acid, though most other evidence for graviola remains at the preclinical (animal and cell-culture) stage. Overall, scientific support for human health benefits is preliminary, and the ingredient carries important safety considerations that consumers should review before use.
What Is Graviola (Soursop)?
Graviola (Annona muricata L.) is an evergreen tree in the Annonaceae family native to the tropical Americas. Its large, green, spiny fruit - commonly called soursop in English, guanabana in Spanish, or corossol in French - has been consumed as food and traditional medicine for centuries across the Caribbean, Central and South America, and West Africa.
The fruit pulp is sweet-tart and nutritious, providing vitamin C, B vitamins (B1, B2), and minerals including potassium, magnesium, and iron. Virtually every part of the tree - leaves, bark, seeds, and roots - has been used in folk medicine, though the parts used medicinally and the amounts that are safe differ importantly.
Traditional uses
Ethnobotanical records show graviola leaves being brewed as teas to help manage headaches, insomnia, muscle pain, and high blood pressure. The fruit has been used as a food for fever management and as a general tonic. A 2022 review in Molecules analyzing 49 research articles from 1981 to 2021 confirmed that antihypertensive, antidiabetic, antimicrobial, and antioxidant applications account for the majority of documented traditional and pharmacological uses.11
How it differs from other Annona species
Annona muricata is one of roughly 170 species in the Annona genus. The closely related cherimoya (A. cherimola) and sugar-apple (A. squamosa) share some bioactive compounds but are distinct species with different phytochemical profiles. The terms "graviola" and "soursop" both refer specifically to A. muricata.
In supplement form, graviola is most commonly sold as a standardized leaf extract in capsule or tablet form, or as powdered fruit pulp. The leaf is where the highest concentration of bioactive compounds is found.5
How Does It Work? Key Bioactive Compounds
Graviola's potential health-supporting properties are attributed to a rich and varied phytochemical profile. Research has identified several classes of bioactive compounds that work through different mechanisms.2
Polyphenols and flavonoids
The leaf and fruit contain an array of polyphenolic antioxidants that have been identified by HPLC analysis, including:
- Quercetin - a well-studied flavonol with antioxidant and anti-inflammatory properties
- Rutin - a flavonoid glycoside known to support vascular health
- Kaempferol - linked to antioxidant enzyme activity
- Gallic acid and catechin - plant polyphenols with broad free-radical scavenging activity
- Luteolin and emodin - identified in methanolic leaf extracts4
A 2023 review in Nutrients confirmed that rutin, kaempferol, and quercetin are among the three dominant phenolic compounds in graviola and that the plant contains minerals including potassium, calcium, iron, copper, and magnesium.2
Annonaceous acetogenins
Graviola also contains a family of bioactive lipid-derived compounds called annonaceous acetogenins - more than 100 have been isolated from A. muricata to date.2 These compounds appear to influence mitochondrial energy metabolism. They are also responsible for certain safety concerns described in the Safety section below.
Alkaloids and other compounds
Additional bioactives include alkaloids (coreximine, reticuline) and essential oil components.11 Together, this diverse phytochemical matrix likely explains the plant's traditional reputation as a broad-spectrum wellness botanical.
Antioxidant Support: What the Research Shows
The most consistently documented property of graviola across laboratory studies is its antioxidant activity - the ability of its polyphenols to neutralize reactive oxygen species (free radicals) that contribute to cellular aging and oxidative stress.
What the research shows
Multiple in vitro (laboratory) studies have measured graviola's antioxidant capacity using standard assays:
- In a 2020 study published in Plants, acidified ethanolic leaf extract achieved DPPH radical-scavenging capacity of 23.61 mmol Trolox equivalents per gram and ABTS capacity of 24.91 mmol TE/g. The same extract inhibited hemolysis (oxidative damage) in human red blood cells by 51.21%.3
- An HPLC analysis of soursop leaf extracts identified eight key phenolic compounds - including quercetin, luteolin, and emodin - and found a strong positive correlation between total phenolic content and free-radical scavenging capacity. The methanolic extract also provided measurable protection against hydrogen peroxide-induced DNA damage in laboratory assays.4
- Analysis of leaf, fruit pulp, root bark, and seeds found that leaf and fruit pulp demonstrated the highest antioxidant potential among all plant parts tested, attributed to high concentrations of phenolics, flavonoids, and alkaloids.5
- A 2025 pharmacological study of Indonesian A. muricata leaves confirmed strong antioxidant capacity in both DPPH and FRAP assays, identifying gallic acid, catechin, quercetin, and rutin as the primary contributors.6
A comprehensive 2023 review in Nutrients synthesized these findings and noted that antioxidant effects have been demonstrated across numerous assays in cell and animal models, with the author emphasizing that human clinical trial data on antioxidant outcomes specifically remains limited, and that most findings are based on in vitro and animal experiments.2
Evidence grade: Tier C (preclinical data suggest antioxidant activity is robust; human evidence has not yet been established for this specific outcome).
Immune and Inflammatory Response Support
Traditional herbalism has long used graviola to support the body's natural defenses. Preclinical research provides some mechanistic plausibility for these uses, though direct human evidence is not yet available.
What the research shows
Macrophage activation (cell study): A 2016 study in Evidence-Based Complementary and Alternative Medicine found that standardized graviola leaf extract activated RAW 264.7 macrophages (key immune cells) through MAP kinase signaling pathways (JNK, ERK, and p38), leading to increased expression of TNF-alpha and IL-1beta - cytokines associated with immune surveillance. Both steam and ethanolic extracts produced consistent activation patterns. The authors proposed a role as a functional food ingredient to support immunity in individuals with suppressed immune function, though this work was conducted entirely in cell culture and has not yet been replicated in humans.8
Reduction of oxidative responses in immune cells (animal study): A 2022 study published in Pharmaceutics tested a polyphenol-rich fraction from graviola leaves in mice and in cultured immune cells. At 10 µg/mL, the ethyl acetate fraction reduced reactive oxygen species (ROS) generation in neutrophils to approximately 3% of control levels. Oral administration at 30 mg/kg in an acute lung injury model significantly decreased protein oxidation markers and preserved glutathione levels, a key endogenous antioxidant.7
Anti-inflammatory activity (animal study): In rodent models, an aqueous fruit extract reduced carrageenan-induced paw edema by 80.85% at 200 mg/kg and inhibited COX-2 activity by 55.71% in laboratory assays at 100 µg/mL - a level of activity comparable to reference anti-inflammatory compounds tested in the same study.9 A separate 2025 study found anti-inflammatory effects from leaf extract comparable to the standard drug indomethacin in edema models.6
Evidence grade: Tier C (preclinical data suggest immune-cell and anti-inflammatory activity; human evidence has not been established).
Blood Pressure and Metabolic Health: Closest to Human Evidence
Of all the proposed benefits of graviola, blood pressure support has the strongest - and only - direct human clinical trial evidence to date.
What the research shows
Randomized controlled trial (human): A 2020 RCT published in the Journal of Human Hypertension enrolled 143 adults meeting prehypertensive criteria under the 2017 ACC/AHA guideline and randomly assigned them to receive two 100 g servings (200 g total) of soursop fruit juice per day for 12 weeks, or no intervention. At both 6 and 12 weeks, the treatment group showed significantly lower systolic blood pressure and significantly lower serum uric acid levels compared to controls. Rates of progression to full hypertension were also lower in the soursop group. The authors concluded that soursop supplementation "can lower BP and SUA [serum uric acid] levels."1
The flavonoids and high potassium content in soursop fruit pulp are the most likely contributors to blood pressure modulation, consistent with known mechanisms of dietary polyphenols and mineral balance in vascular health.2
Important caveats
- This is a single trial with 143 participants and no blinding; independent replication is needed before drawing strong conclusions.
- The intervention was whole fruit juice, not a concentrated supplement; equivalence to commercial extracts cannot be assumed.
- The Annona muricata pharmacological activities review (2022) identified antihypertensive effects as one of the nine documented activity categories across 49 studies, though most evidence was preclinical.11
Evidence grade: Tier B for blood pressure support specifically (one human RCT; Tier A confirmation requires independent replication). Tier C for all other metabolic outcomes.
Relaxation and sleep support
Traditional use of graviola leaf tea for insomnia and anxiety is supported by one preclinical mechanism: a 2018 animal study published in the Iranian Journal of Pharmaceutical Research found that hydroalcoholic leaf extract produced sedative effects at doses of 25-100 mg/kg and anxiolytic effects at 100 mg/kg in mice. Partial reversal with a benzodiazepine receptor antagonist (flumazenil) suggests interaction with GABAergic pathways. Quercetin and kaempferol were identified as likely active constituents.10 No human trials on sleep or anxiety have been conducted. These findings are Tier C and cannot be generalized to human use without clinical confirmation.
Safety, Side Effects, and Important Precautions
Graviola carries a more complex safety profile than many botanical supplements. Consumers should review these points carefully before use.
Overall safety at studied doses
A 2020 systematic review in the Journal of Pharmacy and Pharmacology examined safety data across in vitro, animal, and human studies and concluded that A. muricata leaf extract has "a favourable safety and tolerability profile" at studied doses. Human studies testing up to 300-540 mg of leaf extract daily reported no grade 3 or 4 adverse events.13 Animal toxicity studies found no adverse effects at doses up to 5,000 mg/kg in acute exposure models.6
Neurotoxicity risk from high or prolonged consumption
This is the most critical safety concern. Graviola - and related Annona species - contain annonacin, an acetogenin that inhibits mitochondrial Complex I (NADH:ubiquinone oxidoreductase). A landmark 2005 study in Movement Disorders measured annonacin content across different preparations:
- A typical soursop fruit: approximately 15 mg of annonacin
- A standard can of commercial soursop nectar: approximately 36 mg
- A single cup of leaf infusion or decoction: approximately 140 micrograms
The authors estimated that consuming one fruit or one can of nectar daily would deliver, over one year, an amount of annonacin comparable to that which induced brain lesions in animal models. An epidemiological association between high, prolonged soursop consumption and an atypical form of parkinsonism observed in Guadeloupe has been reported in the scientific literature.12
Practical implication: Occasional consumption of the fruit as food is not in the same risk category as daily high-dose supplementation or regular leaf tea consumption over months. Standardized leaf extract supplements standardized for polyphenols (not for acetogenins) and used at recommended doses appear to carry lower risk, but long-term human safety data remain limited.
Contraindications
- Pregnancy and breastfeeding: Insufficient human safety data. Avoid use.
- Parkinson's disease or other movement disorders: The neurotoxicity mechanism described above is a direct contraindication.
- Liver conditions: The same systematic review noted hepatoprotective effects at low doses but potential hepatotoxic signals at higher exposures; use with caution in individuals with liver disease.13
Drug interactions
- Antihypertensive medications: Additive blood pressure-lowering effects are plausible given the human RCT data; monitor blood pressure closely if combining.1
- Dopaminergic medications (e.g., levodopa): The annonacin-associated mechanism affecting dopaminergic neurons warrants caution.
- CYP450-metabolized drugs: Some preclinical data suggest possible interactions; consult a pharmacist or healthcare provider before combining with prescription medications.
Seeds are toxic
The seeds of the soursop fruit contain concentrated toxic compounds and must never be consumed. Remove all seeds before eating the fruit.
As with any supplement, consult a qualified healthcare provider before starting graviola, especially if you take prescription medications or have existing health conditions.
Graviola Dosage: What Studied Preparations Used
No universal clinical dosage has been established for graviola supplements. The following reflects doses used in published research or documented in safety reviews. These are not prescriptive recommendations; consult a healthcare provider to determine what is appropriate for you.
| Goal | Typical Dose | Timing | Notes |
|---|---|---|---|
| Blood pressure and uric acid support (studied in human RCT) | 200 g soursop fruit juice (two 100 g servings) | Twice daily with meals | Based on one 12-week RCT (n=143 prehypertensive adults). Whole fruit juice, not concentrated extract. Do not combine unsupervised with antihypertensive medication. |
| General antioxidant support - leaf extract capsules | 300-540 mg standardized leaf extract | Once daily with food | Lowest dose shown favorable in human safety review. Use products standardized for polyphenol content. Limit duration; long-term safety data are lacking. |
| Upper end of studied supplemental range | 1,060 mg leaf extract | Divided doses, twice daily with food | Evaluated in a clinical study protocol (12-week safety study). Only attempt under medical supervision. This is not a commonly recommended starting dose. |
| Traditional leaf tea (folk use) | 2-3 g dried leaf per cup | 1-2 cups per day, maximum 2-4 weeks | Traditional use only; annonacin content in decoctions is higher than in fruit pulp per serving. Prolonged daily use of leaf teas is not recommended given neurotoxicity concerns. |
Seeds contain concentrated toxic compounds and must never be consumed in any form. Always remove seeds before eating the fresh fruit.
Graviola (Soursop) - What the Evidence Shows at a Glance
Evidence tiers: A = human RCT or meta-analysis; B = human observational or single small RCT; C = animal or cell studies only.
| Health Outcome | What Studies Show | Study Type | Evidence Strength |
|---|---|---|---|
| Systolic blood pressure reduction | Significant reduction vs. control at 12 weeks (200 g juice/day, n=143) | Human RCT | Tier B (single trial; needs replication) |
| Serum uric acid reduction | Significantly lower uric acid vs. control at 6 and 12 weeks | Human RCT | Tier B (same single trial) |
| Free-radical scavenging (DPPH/ABTS) | Leaf extract: 23-25 mmol Trolox equivalents/g; strong in vitro activity | In vitro (cell-free) | Tier C |
| Protection of red blood cells from oxidative damage | 51% inhibition of hemolysis at highest extract concentration | In vitro (human erythrocytes) | Tier C |
| Macrophage immune activation | MAP kinase pathway activation; increased TNF-alpha and IL-1beta in RAW macrophages | Cell culture | Tier C |
| Anti-inflammatory activity | Up to 80.85% paw edema inhibition; COX-2 inhibition 55.71% | Animal (rodent) | Tier C |
| Sedative / anxiolytic effects | Sedation at 25-100 mg/kg; anxiolytic at 100 mg/kg; partial GABA-A reversal | Animal (mouse) | Tier C |
| Antioxidant enzyme support (SOD, CAT, GSH) | Improved markers in lung injury model; reduced protein oxidation | Animal (mouse) | Tier C |
Tier C findings from animal and cell models cannot be assumed to translate directly to the same magnitude of effect in humans. The only human RCT (blood pressure) used whole fruit juice, not standardized supplements.
Frequently Asked Questions
What is Graviola (Soursop) good for?
Graviola is most studied for antioxidant support (neutralizing free radicals via its polyphenols - quercetin, rutin, kaempferol) and blood pressure support. One 12-week human trial found soursop juice significantly reduced systolic blood pressure in prehypertensive adults. Preclinical data also point to immune-cell support and anti-inflammatory activity, though these findings have not yet been confirmed in human trials.
How much Graviola should I take?
The only human trial used 200 g of soursop fruit juice twice daily for 12 weeks. For standardized leaf extract supplements, human safety studies have evaluated 300-540 mg daily. There is no universally established clinical dose. Start at the lower end of what your supplement label indicates, and consult a healthcare provider, especially if you take any medications.
Is Graviola (Soursop) safe?
At studied supplemental doses (300-540 mg leaf extract daily for up to 30-90 days), a 2020 systematic review found a favorable safety profile. However, high or prolonged consumption - especially of leaf teas and fruit nectar daily over months - is associated with a neurotoxicity risk tied to a compound called annonacin. The seeds are toxic and must never be eaten. Long-term safety data in humans are lacking.
Does Graviola help with blood pressure?
One randomized controlled trial in 143 prehypertensive adults found that 200 g of soursop juice per day for 12 weeks significantly lowered systolic blood pressure and serum uric acid compared to no treatment. This is promising but comes from a single unblinded trial and has not yet been independently replicated. Do not use graviola as a substitute for prescribed antihypertensive therapy.
What does Graviola leaf tea do?
Traditional use includes soursop leaf tea for headaches, insomnia, and blood pressure. Preclinical animal research found leaf extract produced sedative and anxiolytic effects likely through GABAergic pathways. However, leaf decoctions contain higher concentrations of annonacin (a neurotoxic compound) than fruit pulp. Daily long-term use of leaf tea is not recommended given this safety concern.
Can Graviola help with inflammation?
Animal studies show meaningful anti-inflammatory activity: soursop fruit extract reduced carrageenan-induced paw edema by up to 80% and inhibited COX-2 activity by roughly 56% at test concentrations. A 2025 study found results comparable to the pharmaceutical anti-inflammatory indomethacin in rodent models. These are animal findings only - no controlled human trial has tested graviola for inflammatory markers.
Does Graviola help with sleep or anxiety?
Animal research suggests graviola leaf extract may support relaxation through GABAergic and monoaminergic pathways, producing sedative effects at doses of 25-100 mg/kg in mice. Quercetin and kaempferol are the proposed active compounds. No human clinical trials on sleep or anxiety have been conducted. Tier C evidence only - approach with caution and talk to a healthcare provider.
What are the side effects of Graviola?
At studied doses, serious side effects are uncommon in short-term human data. Known concerns include: potential neurotoxicity with high or prolonged use (linked to the compound annonacin); possible drug interactions with antihypertensive or dopaminergic medications; and potential liver stress at excessive doses. Seeds are toxic. Individuals with Parkinson's disease, movement disorders, or liver conditions should avoid graviola supplements.
Can I take Graviola while pregnant or breastfeeding?
No. There are insufficient human safety data for graviola supplements during pregnancy or breastfeeding, and the potential neurotoxic compounds present in some preparations make caution especially warranted. Avoid all graviola supplements and high-dose leaf preparations during pregnancy and nursing. Eating small amounts of the fresh fruit pulp as part of a normal diet carries a different and much lower risk profile.
What is the difference between Graviola and Soursop?
They are the same plant - Annona muricata L. "Graviola" is the Portuguese and widely used supplement-industry name (originating from Brazil), while "soursop" is the common English name. "Guanabana" is the Spanish name used across Latin America. All three names refer to the same species; you may see any of these on product labels.
Shop Graviola (Soursop)
HealthFare Graviola (Soursop) supplements
Scientific References
- 1.Alatas H, Sja'bani M, Mustofa M, Mukti AG, Bawazier LA, Irijanto F, Zulaela Z, Tomino Y The effects of soursop supplementation on blood pressure, serum uric acid, and kidney function in a prehypertensive population in accordance with the 2017 ACC/AHA guideline. Journal of Human Hypertension. 2020. PubMed: 31462727Human observational
- 2.Olas B The Antioxidant Potential of Graviola and Its Potential Medicinal Application. Nutrients. 2023. PubMed: 36678273Preclinical (animal / cell)
- 3.Balderrama-Carmona AP, Silva-Beltran NP, Galvez-Ruiz JC, Ruiz-Cruz S, Chaidez-Quiroz C, Moran-Palacio EF Antiviral, Antioxidant, and Antihemolytic Effect of Annona muricata L. Leaves Extracts. Plants (Basel). 2020. PubMed: 33256023Preclinical (animal / cell)
- 4.George VC, Kumar DRN, Suresh PK, Kumar RA Antioxidant, DNA protective efficacy and HPLC analysis of Annona muricata (soursop) extracts. Journal of Food Science and Technology. 2015. PubMed: 25829616Preclinical (animal / cell)
- 5.Agu KC, Okolie PN Proximate composition, phytochemical analysis, and in vitro antioxidant potentials of extracts of Annona muricata (Soursop). Food Science and Nutrition. 2017. PubMed: 28948021Preclinical (animal / cell)
- 6.Oufquir S, Agouram F, Kabdy H, Ait Laaradia M, Oubella K, Abdelmoniim B, Rachida A, Garzoli S, Chait A Novel Insights Into the Bioactive Profile and Therapeutic Potentials of Indonesian Annona muricata Leaves. Chemistry and Biodiversity. 2025. PubMed: 40829062Preclinical (animal / cell)
- 7.Saraiva AL, Justino AB, Franco RR, Silva HCG, Arruda FDS, Klein SG, Celes MRN, Goulart LR, Espindola FS Polyphenols-Rich Fraction from Annona muricata Linn. Leaves Attenuates Oxidative and Inflammatory Responses in Neutrophils, Macrophages, and Experimental Lung Injury. Pharmaceutics. 2022. PubMed: 35745755Preclinical (animal / cell)
- 8.Kim GT, Tran NKS, Choi EH, Song YJ, Song JH, Shim SM, Park TS Immunomodulatory Efficacy of Standardized Annona muricata (Graviola) Leaf Extract via Activation of Mitogen-Activated Protein Kinase Pathways in RAW 264.7 Macrophages. Evidence-Based Complementary and Alternative Medicine. 2016. PubMed: 28096884Preclinical (animal / cell)
- 9.Ishola IO, Awodele O, Olusayero AM, Ochieng CO Mechanisms of Analgesic and Anti-Inflammatory Properties of Annona muricata Linn. (Annonaceae) Fruit Extract in Rodents. Journal of Medicinal Food. 2014. PubMed: 25133801Preclinical (animal / cell)
- 10.Souza DO, dos Santos Sales V, et al. Phytochemical Analysis and Central Effects of Annona Muricata Linnaeus: Possible Involvement of the Gabaergic and Monoaminergic Systems. Iranian Journal of Pharmaceutical Research. 2018. PubMed: 30568689Preclinical (animal / cell)
- 11.Mutakin M, Fauziati R, Fadhilah FN, Zuhrotun A, Amalia R, Hadisaputri YE Pharmacological Activities of Soursop (Annona muricata Lin.). Molecules. 2022. PubMed: 35208993Preclinical (animal / cell)
- 12.Champy P, Melot A, Guerineau Eng V, Gleye C, Fall D, Hoglinger GU, Ruberg M, Lannuzel A, Laprevote O, Laurens A, Hocquemiller R Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in guadeloupe. Movement Disorders. 2005. PubMed: 16078200Preclinical (animal / cell)
- 13.Chan WJ, McLachlan AJ, Hanrahan JR, Harnett JE The safety and tolerability of Annona muricata leaf extract: a systematic review. Journal of Pharmacy and Pharmacology. 2020. PubMed: 31659754Preclinical (animal / cell)